semaglutide weight loss papillion Scale Down Clinic — Medical Weight Loss in GLP-1 Therapy for Weight Loss

Consideration of potential drug interactions and whether discussions have occurred with a primary care provider

Inden, M

Examples: schedule workouts like appointments, prep two meals per week in advance, keep alcohol out of sight, and enlist a friend as an accountability partner

WEGOVY is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)

However, the results could vary from person to person, depending on individual factors, skin condition, and genetic considerations

Wylie, L